Genalyte Spectrum Solutions Saliva Collection Device, Access Bio, Genalyte Coronavirus Tests Get FDA EUAs Spectrum Solutions' specimen collection device is used with SARS-CoV-2 saliva tests from DxTerity Diagnostics and RUCDR Infinite Biologics. Genalyte Focuses on Rheumatology as It Moves Maverick Platform to the Clinic Premium The company said this week that is has raised $36 million in funding, as it continues efforts to develop its Maverick platform for rapid testing in doctors' offices. Genalyte Raises $36M in Funding The company said it will use the funds to further refine its Maverick Detection System for rapid blood testing in outpatient settings like doctors' offices. Genalyte to Use $44M Funding Round to Pursue FDA Clearance for Multiplexed Immunoassay Device Premium The company is preparing a clinical study through which it will collect data that it will use to submit the device to FDA for 510(k) clearance next year. Genalyte Raises $44M in Series C Financing The San Diego diagnostics firm's technology is designed for rapid, multiplexed, blood-based testing in a physician's office setting. Feb 3, 2015 Genalyte, Collaborators Gear Up for Phase Two of Tumor-associated Antigen Panel Development Premium Jan 20, 2015 Genalyte Developing Differential Ebola Test for Maverick Chip-based System Premium Oct 18, 2013 Genalyte Awarded $1M SBIR Grant to Develop Cancer Biomarker Panel Sep 3, 2013 In U of Colorado Partnership, Genalyte Expands New Diabetes Research Panel Premium Aug 16, 2013 New Products: Biognosys, Genalyte, Digital Proteomics Premium Aug 15, 2013 Genalyte to Collaborate with Davis Center on Diabetes Panel Aug 9, 2013 Poly-NYU Team's Whispering Gallery Resonance Mode Biosensor Achieves Detection of Single Proteins Premium Apr 12, 2013 New Products: Quest Diagnostics, Genalyte Premium Mar 26, 2013 Distribution Deals Brings Genaltye Maverick Detection System to Europe Dec 18, 2012 Genalyte Developing Early Detection Diabetes Test, Planning 2013 FDA Submission for Autoimmune Panel Premium Dec 11, 2012 Genalyte Receives $500K SBIR Grant for Diabetes Assay Development Sep 25, 2012 New Products: NanoString's Single Cell Gene Expression Application, Genalyte's Custom Spotting Service, InDevr's Custom Arrays Premium Sep 19, 2012 Genalyte, Scienion Ink Marketing Pact Jul 27, 2012 New Products: MS3 from Proteome Sciences and More Premium Mar 30, 2012 Multiplexing Technology Firm Genalyte Raises $11.8M in Series B Round Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.